1. Home
  2. ZLAB vs CNO Comparison

ZLAB vs CNO Comparison

Compare ZLAB & CNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CNO
  • Stock Information
  • Founded
  • ZLAB 2013
  • CNO 1979
  • Country
  • ZLAB China
  • CNO United States
  • Employees
  • ZLAB N/A
  • CNO N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CNO Accident &Health Insurance
  • Sector
  • ZLAB Health Care
  • CNO Finance
  • Exchange
  • ZLAB Nasdaq
  • CNO Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CNO 3.8B
  • IPO Year
  • ZLAB 2017
  • CNO 1987
  • Fundamental
  • Price
  • ZLAB $32.54
  • CNO $36.62
  • Analyst Decision
  • ZLAB Buy
  • CNO Hold
  • Analyst Count
  • ZLAB 5
  • CNO 6
  • Target Price
  • ZLAB $54.28
  • CNO $41.00
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • CNO 757.1K
  • Earning Date
  • ZLAB 08-05-2025
  • CNO 07-28-2025
  • Dividend Yield
  • ZLAB N/A
  • CNO 1.73%
  • EPS Growth
  • ZLAB N/A
  • CNO N/A
  • EPS
  • ZLAB N/A
  • CNO 2.88
  • Revenue
  • ZLAB $418,326,000.00
  • CNO $4,297,100,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CNO N/A
  • Revenue Next Year
  • ZLAB $49.13
  • CNO $3.06
  • P/E Ratio
  • ZLAB N/A
  • CNO $12.83
  • Revenue Growth
  • ZLAB 43.72
  • CNO N/A
  • 52 Week Low
  • ZLAB $16.01
  • CNO $28.41
  • 52 Week High
  • ZLAB $44.34
  • CNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • CNO 38.84
  • Support Level
  • ZLAB $34.26
  • CNO $36.60
  • Resistance Level
  • ZLAB $35.72
  • CNO $39.02
  • Average True Range (ATR)
  • ZLAB 1.12
  • CNO 0.74
  • MACD
  • ZLAB -0.54
  • CNO -0.15
  • Stochastic Oscillator
  • ZLAB 3.83
  • CNO 5.05

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CNO CNO Financial Group Inc.

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

Share on Social Networks: